Branching morphogenesis within the peripubertal mouse mammary gland is directed by progesterone (P). A role for the homeobox-containing transcription factor, Msx2, during branching morphogenesis is suggested from its ontogenic expression profile and hormonal regulation. Herein, we define the spatio-temporal control of Msx2 expression, the regulation of its expression by P and its direct role in ductal branching morphogenesis. P induces Msx2 in the presence of estrogen (E) both in vitro and in vivo while absence of the P receptor (PR) decreased Msx2 expression. Stable transfection of PR into mouse mammary epithelial cells increased the endogenous expression of Msx2 and their ability to undergo branching morphogenesis in vitro. Furthermore, normal mammary cells stably-transfected with Msx2 demonstrated increased branching morphogenesis in vitro while transgenic mice expressing Msx2 in their mammary glands demonstrated enhanced lateral branching during early development. The action of P on branching morphogenesis appears to involve Bmp2/4. Together, these data demonstrate that P, acting through PR-A and the Bmp2/4 pathway, induces Msx2 to enhance ductal branching in the mammary glands.
Introduction
Homeobox-containing genes are major regulators of developmental pathways in the embryo and are modulated by hormones (Chen and Sukumar, 2003) . The murine homologues of the Drosophila muscle segment homeobox gene, Msx1, Msx2 and Msx3, are chromosomally unlinked, residing on chromosomes 5, 13 and 7 respectively (Davidson, 1995) . Msx1 and Msx2 are expressed in many developing tissues including craniofacial structures, limbs and the mammary gland (Alappat et al., 2003; Satoh et al., 2004) , whereas Msx3 is expressed only in the developing central nervous system (Wang et al., 1996) .
Msx2 transcripts are present in mammary glands of embryonic, nulliparous and early pregnant mice (Daniel and Smith, 1999) . However, their level decreases dramatically during late pregnancy and following ovariectomy (Friedmann and Daniel, 1996; Phippard et al., 1996) , suggesting hormonal regulation. Both Msx1 and Msx2 are expressed in the developing epithelium and stroma of the mammary gland (Lewis, 2000) . The detection of Msx2 expression in the periductal, but not in epithelium-free, stroma suggests that stromal Msx2 expression is regulated by epithelial-stromal interaction. Additionally, Msx2-deficient mice exhibit epithelial development that is arrested at the mammary sprout stage equivalent to E16.5 (Satokata et al., 2000) , suggesting that Msx2 acts to promote early branching morphogenesis of the mammary epithelium.
Previously, we showed that progesterone (P) induces side-branching of the ductal epithelium in the peripubertal mouse mammary gland (Atwood et al., 2000) . P receptor (PR) is critical for branching morphogenesis (Fernandez-Valdivia et al., 2005) and localizes to ductal branch points during mouse mammary development (Ismail et al., 2002) . Coincidently, the temporal expression of Msx2 in the mammary gland during development parallels that for PR (Hovey et al., 2001) . Given that Msx2 is upregulated by P in T47D human breast cancer cells (Richer et al., 2002) , we hypothesized that P enhances branching morphogenesis of the mouse mammary gland through upregulation of Msx2. The results herein support this hypothesis where Msx2 induces branching morphogenesis in the mammary epithelium both in vitro and in vivo. Regulation of Msx2 expression by P and its coordinated regulation with PR leads us to conclude that this homeobox factor is a key local effector of P-induced branching morphogenesis.
Results
Levels of Msx2 mRNA significantly changed during mammary gland development (Figure 1a ), consistent with a potential role in branching morphogenesis. Elevated levels corresponded to periods of ductal development and branching morphogenesis in the glands of nulliparous animals while its expression was downregulated during pregnancy and lactation, reflecting different mechanisms regulating branching at different stages of development. Msx2 gene expression subsequently increased during involution where its role during gland remodeling remains to be explored. In situ hybridization (Figures 1b and c) showed the majority of Msx2 expression in the epithelium and lesser amounts in stromal cells near the ductal epithelium in glands from 12-week-old mice. Expression of Msx2 in the mammary ductal epithelium was punctate and clustered as we reported for PR expression (Hovey et al., 2001) .
As development of the mammary gland is tightly regulated by hormones (Hovey et al., 2002) , where its branching morphogenesis is regulated by P (Atwood et al., 2000) , we investigated the effect of P on Msx2 gene expression. Both estrogen (E) and P treatment increased Msx2 expression in mammary glands from ovary-intact mice (Figure 2a ). After 9 days treatment, E increased expression twofold and P increased it fourfold; E þ P was less stimulatory than P alone, suggesting a competitive role of E vs P or a critical effect of time and concentration of hormone exposure. In many hormonal systems, the ratio of two hormones can be as important as the absolute concentrations. In ovariectomized mice (Figure 2b ), Msx2 gene expression was significantly reduced while exogenous E, but not P, partially restored its expression. When administered with E, P restored Msx2 expression to control levels, thereby suggesting that E is essential for P to induce Msx2 transcription in vivo.
Furthermore, the level of Msx2 expression in mammary glands from 5-week-old PR knockout (PRKO) female mice, at a time when branching morphogenesis is normally underway (Hovey et al., 2002) , was significantly reduced (Figure 2c ). By contrast, there was no difference in the level of Msx2 mRNA in the mammary glands of wild-type and PRKO mice at 12 weeks of age when the active process of branching morphogenesis has significantly diminished. Similar results were seen in mammary glands from 5-week-old PRKO female mice by in situ hybridization (Figures 2d and e) .
Since P has been shown to play an important role in breast cancer (Lee et al., 2006) and homeobox genes, including Msx2, are overexpressed in several cancers (Abate-Shen, 2002), we examined the regulation of Msx2 by P in ER/PR-positive MC4-L3 mouse mammary carcinoma cells (Lanari et al., 2001) . These cells express a low level of Msx2 (Figure 2f ). Consistent with our data in vivo, when P þ E were added to the media these cells demonstrated a significant (twofold) increase in Msx2 expression.
To investigate the mechanism of P regulation of Msx2 expression, we utilized the PR-negative EpH4-WT normal mouse mammary epithelial cells that express low levels of Msx2. Clonal populations of cells stably transfected with mPR (EpH4-PR) express PR mRNA ( Figure 3A ). By immunocytochemistry we found that an antibody specific to PR-A ( Figure 3B ) stained the EpH4-PR cells; no stain was seen with a PR-B-specific antibody (Mote et al., 2002) . Neither antibody stained the EpH4-EV cells. Concomitant with overexpression of PR-A, EpH4-PR cells demonstrated an increased level of Msx2 mRNA ( Figure 3C ). An additional increase in Msx2 transcription occurred upon supplementation with P. Effects of unliganded PR have been reported for the PR-A (Bamberger et al., 1996) .
The action of P during branching and lobulo-alveolar development in the mammary glands during early pregnancy is purportedly mediated by signaling through Wnt4 (Brisken et al., 2000) . In teratocarcinoma cells, Msx2 expression is increased over 20-fold by Wnt þ Bmp (Willert et al., 2002) . Hence, the Wnt inhibitor Dkk1 (Nusse, 2001) did not alter the level of Msx2 expression in EpH4-PR cells (Figure 4a ). Furthermore, while we could detect Wnt4, Wnt5a and Wnt10b in mouse mammary tissue by western blotting, these were undetected in EpH4-PR cells. In contrast, the level of expression of Msx2 transcripts in EpH4-PR was significantly decreased after exposure to the Bmp inhibitor, Noggin (Smith and Harland, 1992) (Figure 4b ). Progesterone, Msx2 and branching in mammary glands K Satoh et al Conversely, addition of Bmp2 or Bmp4 to EpH4-WT cells significantly upregulated expression of Msx2 (Figures 4c-e) .
EpH4-PR cells demonstrated significant branching in collagen gel (Figure 5a) , even in the absence of P.
Addition of P resulted in branching comparable to that of EpH4-EV cells treated with hepatocyte growth factor (HGF), a known regulator of branching morphogenesis in the mammary gland . Additionally, the Bmp2/4 pathway is sufficient to support branching (Figures 7d and e) . At the onset of pregnancy (Figures 7c and f) and thereafter (not shown), differences between transgenic and wild-type mice were no longer apparent. Extensive ductal dilation was present in mammary glands from 54% (11/22) of the nulliparous transgenic mice over 12 months of age (Figure 7g ) compared to only 6% (1/16) of agematched wild-type mice. In nulliparous mice over 16 months of age, localized hyperplasias ( Figure 7h ) were seen in glands from 33% (6/18) of MMTV-Msx2 mice; no hyperplasias were seen in glands from control mice.
Discussion
While it is firmly established that hormones such as P (Atwood et al., 2000) and PRL (Kelly et al., 2002) alone, and in combination (Hovey et al., 2001) , regulate branching morphogenesis in ductal epithelium the downstream local effectors of their actions have not been resolved. Our findings suggest that one such contributor to P-induced branching morphogenesis is Msx2, a member of a large family of homeobox genes that play essential roles in a variety of developmental patterning events (Capecchi, 1997) . In keeping with our findings, deletion of Msx2 impairs formation of a branched mammary placode in the glands of neonates during ductal branching morphogenesis in the embryo (Satokata et al., 2000) .
The development of the fully branched mammary gland is the result of both cell proliferation and migration under the influence of a variety of hormones and growth factors working in concert. A role for IGF-1 in the branching we have described cannot be eliminated. Indeed, Ruan et al. (2005) have shown that in the absence of E, IGF-1 and P act synergistically to develop the branched ductal tree. During branching, IGF-1 and E (Zhang et al., 2002) act indirectly on the epithelium through the stroma while our data indicate that P acts directly on the epithelium.
Elevated levels of PR in the branching mammary ducts during puberty (Hovey et al., 2001; Ismail et al., 2002) and its expression profile in the mammary glands during other developmental stages aligns closely with the ontogenic profile of Msx2 expression (Figure 1) . Furthermore, both Msx2 and PR localize to regions of ductal branching and are heterogeneously expressed within the mammary epithelium (Figure 2) , where Msx2 expression is reduced in peripubertal PRKO female mice that fail to initiate ductal branching morphogenesis (Ismail et al., 2002) . Our demonstration that P induces Msx2 transcription both in vivo and in vitro concurs with an earlier report (Richer et al., 2002) identifying Msx2 as a transcriptional target of P acting via PR-B in T47D breast cancer cells. However, our results revealed that PR-A alone is sufficient to induce Msx2 expression. The phenotype of mammary glands from both PRAKO and PRBKO peripubertal females indicates either PR isoform can facilitate branching morphogenesis Progesterone, Msx2 and branching in mammary glands K Satoh et al (Mulac-Jericevic et al., 2003) . However, recent work (Aupperlee et al., 2005) showed exclusive expression of PR-A in the mammary glands of peripubertal wild-type mice whereas PR-B localized mainly in alveolar structures during early pregnancy. Further, transgenic mice overexpressing PR-A have extensive lateral ductal branching while those overexpressing PR-B have extensive, precocious alveolar development (Shyamala et al., 2000) . Clearly there is complex regulation of PR isoform expression in the mammary glands and it is likely that effects on Msx2 gene expression are stageand state-specific.
The positive effect of P on Msx2 transcription depends on its cooperation with E consistent with our previous findings on proliferation (Hovey et al., 2001) and branching morphogenesis (Atwood et al., 2000) in the glands of peripubertal mice. Expression of Msx2 alone is not sufficient to cause branching as E cannot induce branching in collagen cultures. This may be due to the fact that E, administered to ovariectomized mice, only partially restored the level of Msx2. Although this interactive effect of E and P on the induction of Msx2 is probably achieved through the pronounced positive effect of E on PR transcription (Haslam, 1988) , there are no canonical ERE or GRE/PRE sites in the murine Msx2 promoter (Malewski et al., 2005) . Hence the regulatory mechanisms that direct Msx2 transcription downstream of PR remain to be resolved.
While hormones such as P regulate branching morphogenesis within the mammary glands, it is ultimately realized through the local action of a cocktail of mitogens and morphogens. Our in vitro and in vivo data indicate that Msx2 is one such morphogen. The effects of Msx2 on branching morphogenesis were comparable Progesterone, Msx2 and branching in mammary glands K Satoh et al to those due to HGF, a recognized stroma-derived morphogen for mammary epithelial cells that also potentiates P-induced alveologenesis in vitro . Additional branching by NMuMG-Msx2 cells upon treatment with HGF suggests that Msx2 and HGF elicit their effects through separate pathways. This finding combined with a role for Bmp2/4 in the induction of Msx2 is similar to the parallel effects of Bmp2 and HGF reported for the regulation of renal collecting duct morphogenesis (Gupta et al., 2000) . To date only a few factors that mediate the action of P on the mammary glands have been identified. Wnt4 is one such factor (Brisken et al., 2000) . Although both Msx1 and Msx2 lie downstream of Wnt signaling in human teratocarcinoma cells (Willert et al., 2002) , we were unable to demonstrate a role for Wnts in branching morphogenesis or Msx2 transcription by EpH4 cells. However, our demonstration of Msx2 regulation by Bmp2/4 follows previous spatio-temporal data suggesting interrelated roles for Msx1 and 2 and Bmp2/4 in development of the branched mammary rudiment (Phippard et al., 1996) . In human teratocarcinoma cells, Bmp4 elicited a more rapid increase in Msx2 expression than Wnt3a and was 5-7 times more effective, while the two pathways synergized to induce maximal Msx2 expression (Willert et al., 2002) . Convergence of the Wnt and Bmp signaling pathways in Msx2-induced branching morphogenesis may depend upon mammary developmental stage. Previous studies (Brisken et al., 2000) dealt with fine branching and alveolar budding during pregnancy, while our studies were performed during the peripubertal period, suggesting that P stimulates early branching through a Bmp2/4 signaling pathway while it utilizes the Wnt4 pathway during pregnancy. This is supported by our transgenic mouse data where the glands from young nulliparous MMTV-Msx2 transgenic mice exhibited enhanced lateral branching, but glands from pregnant transgenic and wild-type mice were indistinguishable. Progesterone, Msx2 and branching in mammary glands K Satoh et al Taken together, these data suggest that P, acting via PR-A and the Bmp2/4 pathway, induces Msx2 expression to induce secondary and tertiary branching in the peripubertal mammary gland. Understanding the individual roles of proliferation and migration in this process as well as which genes are targets of Msx2 in directing branching is currently under investigation.
Materials and methods
Animals BALB/c mice were obtained from the NCI (Frederick, MD, USA) and handled as described in the NIH Guide for the Care and Use of Laboratory Animals. PRKO mice were described previously (Lydon et al., 1996) . Generation and characterization of MMTV-Msx2 transgenic mice is described in Supplementary Information.
Preparation of tissue at different stages of development and hormonal treatments are described in Supplementary Information.
RT-PCR
Total RNA was isolated using TRIzol Reagent (Invitrogen, Gaithersburg, MD, USA). Genomic DNA was removed by treating total RNA with DNase I (Invitrogen) followed by phenol-chloroform extraction and ethanol precipitation. Details of PCR conditions and primer sequences are found in Supplementary Information. Products were resolved on a 2% agarose gel, quantitated using NIH image, and normalized to the respective level of GAPDH mRNA. The PCR conditions were optimized to ensure that amplification was in the linear phase for each primer pair. Appropriate negative controls were included for each RT-PCR.
In situ hybridization Antisense and sense riboprobes were labeled with 35 S using the MAXI script In vitro Transcription kit (Ambion, Austin, TX, USA) during transcription from a 407 bp Msx2 PCR product subcloned into PCR script (Stratagene, LaJolla, CA, USA) as described previously (Hovey et al., 2001) . Sections were exposed to emulsion (NTB-2, Kodak) for 5 weeks and counterstained with nuclear fast red.
Cell culture and transfection Details for culture of each cell line (NMuMG and EpH4 mouse mammary epithelial cells and MC4-L3 mouse mammary adenocarcinoma cells), preparation of stable transfectants and hormonal treatments are described in Supplementary Information. The same passage generation for both the empty-vector control and transfected cells were used in a given experiment.
Collagen gel cultures
Collagen cultures were prepared as described (Wechselberger et al., 2001 ) with 4-5 Â 10 5 cells plated in each 35 mm dish. After 1 h, growth media in the absence or presence of 10 ng/ml (HGF, R&D Systems, Minneapolis, MN, USA) were added to NMuMG-EV or NMuMG-Msx2 cells. Branching was quantified by counting all identifiable branch points within each colony. After 24 h, media for EpH4-EV or EpH4-PR cells were changed to DMEM/CSS alone, or supplemented with P (10 À8 or 10 À6 M) or HGF (10 ng/ml). EpH4-WT cells were grown in the absence or presence of Bmp2 or Bmp4 at 1000 ng/ml. All media were changed every 3 days and cells were monitored for branching morphogenesis up to 17 days.
Immunohistochemistry
EpH4-EV or EpH4-PR cells in collagen gels were first visually identified and dissected out under a microscope, fixed in 10% formalin overnight, embedded in paraffin and subjected to immunohistochemistry using an anti-PR-A antibody (A0098 DAKO, Carpenteria, CA, USA) (Aupperlee et al., 2005) or hPRa6 that recognizes PR-B (Mote et al., 2002) . The primary antibody was detected with peroxidase conjugated anti-rabbit IgG using 3,3 0 -diaminobenzidine (DAB) as chromogen, and counterstained with hematoxylin.
Statistical analyses
All data are expressed as mean7s.e. unless otherwise indicated. Differences were considered significant at Po0.05 as determined by two-way analysis of variance using StatView for the Mac. 
